Short-distance walking speed tests in people with Parkinson disease: Reliability, responsiveness, and validity

Combs, Stephanie A.; Diehl, M Dyer; Filip, Jacqueline; Long, Eric C.

doi:10.1016/j.gaitpost.2013.10.019

Cited by 77 publications

(78 citation statements)

References 30 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The lowest correlation was found with the fall efficacy scale (r = 0.26, P < 0.001) and the fear of falling (r = − 0.25, P < 0.05) (Combs et al, 2014).…”

Section: Construct Validitymentioning

confidence: 81%

“…In most papers included in this review, the MiniBESTest was used to assess balance in patients with Parkinson's disease (Duncan et al, 2011;Leddy et al, 2011;Bergström et al, 2012;Duncan and Earhart, 2012;King et al, 2012;McNeely et al, 2012;Duncan et al, 2013;Mak and Auyeung, 2013;Maia et al, 2013;Combs et al, 2014;Löfgren et al, 2014;Schlenstedt et al, 2015). Postural instability -a key feature of advanced Parkinson's disease -often leads to falls, which is one of the main causes of hospitalization.…”

Section: Discussionmentioning

confidence: 99%

“…Correlations of the Mini-BESTest with many other disease-specific rating scales, comorbidity indices, and instrumented or clinical measures of balance impairment were also reported, showing mostly a moderate to good correlation (Duncan et al, 2011;Tsang et al, 2013;Combs et al, 2014;O'Hoski et al, 2015). The lowest correlation was found with the fall efficacy scale (r = 0.26, P < 0.001) and the fear of falling (r = − 0.25, P < 0.05) (Combs et al, 2014).…”

Section: Construct Validitymentioning

confidence: 95%

“…Most of the selected papers (N = 19, 79%) focused on patients affected by neurological diseases, such as Parkinson's disease (Duncan et al, 2011;Leddy et al, 2011;Bergström et al, 2012;Duncan and Earhart, 2012;King et al, 2012;McNeely et al, 2012;Duncan et al, 2013;Mak and Auyeung, 2013;Maia et al, 2013;Combs et al, 2014;Löfgren et al, 2014;Schlenstedt et al, 2015), subacute (Chinsongkram et al, 2014) or chronic (Bergström et al, 2012;Tsang et al, 2013) poststroke, and other miscellaneous neurological diagnoses (Franchignoni et al, 2010;Padgett et al, 2012;Godi et al, 2013;Franchignoni et al, 2015). The remaining studies included aged cancer survivors (Huang et al, 2015), patients with knee arthroplasty (Chan and Pang, 2015), and healthy individuals (Maia et al, 2013;O'Hoski et al, 2014;O'Hoski et al, 2015;Yingyongyudha et al, 2015).…”

Section: Literature Searchmentioning

confidence: 99%

See 3 more Smart Citations

The Mini-BESTest: a review of psychometric properties

Carlo

Bravini

Vercelli

et al. 2016

International Journal of Rehabilitation Research

View full text Add to dashboard Cite

The Mini-Balance Evaluation Systems Test (Mini-BESTest) has been identified as the most comprehensive balance measure for community-dwelling adults and elderly individuals. It can be used to assess balance impairments in several other conditions, mainly Parkinson's disease and stroke. Despite increasing use of the Mini-BESTest since it was first published 5 years ago, no systematic review synthesizing its psychometric properties is available. The aim of this study was to provide a comprehensive review of the psychometric properties of the Mini-BESTest when administered to patients with balance deficits because of different diseases. A literature search was performed on articles published before July 2015 in journals indexed by MEDLINE and Scopus databases. The search produced 98 papers, 24 of which fulfilled the inclusion criteria for this review. Most papers (n=19) focused on patients affected by neurological diseases, mainly Parkinson's disease. In 21 papers, the psychometric characteristics were analyzed using Classical Test Theory methods and in only three papers was Rasch analysis carried out. This review shows the interest of researchers in the Mini-BESTest despite the short time frame since its first publication. The Mini-BESTest is used widely in both clinical practice and research. The results support the reliability, validity, and responsiveness of this instrument and it can be considered a standard balance measure. However, it would be valuable to learn more about how this scale performs in different diseases causing balance deficits and to better define the minimal clinically important difference for each disease.

show abstract

“…The lowest correlation was found with the fall efficacy scale (r = 0.26, P < 0.001) and the fear of falling (r = − 0.25, P < 0.05) (Combs et al, 2014).…”

Section: Construct Validitymentioning

confidence: 81%

Section: Discussionmentioning

confidence: 99%

Section: Construct Validitymentioning

confidence: 95%

Section: Literature Searchmentioning

confidence: 99%

See 2 more Smart Citations

The Mini-BESTest: a review of psychometric properties

Carlo

Bravini

Vercelli

et al. 2016

International Journal of Rehabilitation Research

View full text Add to dashboard Cite

show abstract

“…Clinical assessments, which included Unified Parkinson's Disease Rating Scale (UPDRS) part II (Peto et al 1995;Zhang and Chan 2012) and 6 Minute Walking Test (6MWT) (Combs et al 2014;Guyatt et al 1985), were collected at the beginning (T0), at the end (T30) and at 3 months after the end of the motor rehabilitation training (T90; Figure 1). …”

Section: Clinical Assessments (Rating Scales)mentioning

confidence: 99%

The effects of motor rehabilitation training on clinical symptoms and serum BDNF levels in Parkinson’s disease subjects

Angelucci

Piermaria

Gelfo

et al. 2016

Can. J. Physiol. Pharmacol.

View full text Add to dashboard Cite

Keyword:https://mc06.manuscriptcentral.com/cjpp-pubs Moreover, parallel treatments in animals up-regulate brain-derived neurotrophic factor (BDNF). Thus, we investigated the effect of a motor rehabilitation protocol on PD symptoms and BDNF serum levels.Motor rehabilitation training consisted of a cycle of 20 days/month of physiotherapy divided in three daily sessions. Clinical data were collected at the beginning, at the end and at 90 days follow-up.BDNF serum levels were detected by ELISA at 0, 7, 14, 21, 30 and 90 days. The follow up period had a duration of 60 days (T30-T90). The results showed that at the end of the treatment (day 30 th ), an improvement in extrapyramidal signs (UPDRS III; UPDRS III -Gait and Balance items), motor (6 Minute Walking Test) and daily living activities (UPDRS II; PDQ-39) was observed. BDNF levels were increased at day 7 th as compared to baseline. After that, no changes in BDNF were observed during the treatment and in the successive follow-up. This study demonstrates that motor rehabilitation training is able to ameliorate PD symptoms and to increase temporarily BDNF serum levels. The latter effect may potentially contribute to the therapeutic action.

show abstract

Measurement Instruments to Assess Functional Mobility in Parkinson's Disease: A Systematic Review

Bouça‐Machado

Duarte

Patriarca³

et al. 2019

Movement Disord Clin Pract

View full text Add to dashboard Cite

Background Background: Functional mobility (FM) is a person's ability to move to accomplish activities of daily living; it bridges the concepts of mobility and functional ability. There is frequently a loss of FM in Parkinson's disease (PD). Several instruments have been used to assess this concept in PD; however, there is no consensus on which are the most appropriate. Objective Objective: We aimed to identify and critically appraise which measurement instruments have been used to assess FM. Methods Methods: A systematic review was conducted using the databases CENTRAL, MEDLINE, Embase, and PEDro from their inception to January 2019 to identify all observational and experimental studies conducted in PD or atypical parkinsonism that included an FM assessment. Two reviewers independently screened citations, extracted data, and assessed clinimetric properties. Results Results: We included 95 studies that assessed FM in PD. Fifty-five (57.9%) studies mentioned FM in the article, and 39 (41.1%) specified the measurement tools used to evaluate FM. FM was the primary outcome in 12 (12.6%) studies. The Timed Up and Go test was the most frequently used measurement tool. Only one study presented a definition of FM. Several overlapping terms were used, the most common being mobility. Conclusion Conclusion: Several studies reported the use of FM measurement tools in PD, though with frequent misconceptions, an inadequate context of use, or suboptimal assessment. We propose the establishment of the concept of FM applied to PD, followed by the adequate clinimetric validation of existing measurement tools to provide a comprehensive and reliable evaluation of FM in PD.

show abstract

Short-distance walking speed tests in people with Parkinson disease: Reliability, responsiveness, and validity

Cited by 77 publications

References 30 publications

The Mini-BESTest: a review of psychometric properties

The Mini-BESTest: a review of psychometric properties

The effects of motor rehabilitation training on clinical symptoms and serum BDNF levels in Parkinson’s disease subjects

Measurement Instruments to Assess Functional Mobility in Parkinson's Disease: A Systematic Review

Contact Info

Product

Resources

About